LAS VEGAS, NV—When used in combination with the calcium channel alpha 2-delta ligands pregabalin and gabapentin, lidocaine 5% patch is well tolerated and safe for postherpetic neuralgia (PHN), ...
AUSTIN, TX—Arash Nafissi, DO, and colleagues of Hospital for Joint Disease, New York University, report that placing a topical Lidoderm patch provides an effective adjunct treatment in post-operative ...
September 28, 2010 (Las Vegas, Nevada) — The use of a transdermal lidocaine 5% patch (Lidoderm, Endo Pharmaceuticals) benefits patients who have undergone unilateral knee replacement surgery by ...
The results of this exploratory study suggest that Lidoderm can alleviate the pain associated with OA of the knee. "The results of this exploratory study suggest that Lidoderm can alleviate the pain ...
An upstate New York pharmaceutical sales representative was among three whistle-blowers to supply information to federal prosecutors leading to a $193 million settlement with makers of the Lidoderm ...
CHADDS FORD, Pa., March 31, 2005 – Today at the 24th Annual Scientific Meeting of the American Pain Society, Endo Pharmaceuticals Inc. released new clinical trial data which found patients receiving ...
A preclinical study commissioned by Alliqua, Inc. (OTCQB: ALQA) ("Alliqua" or "the Company") concluded that the Company's investigational lidocaine transdermal patch compares favorably to the Lidoderm ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from ...
Says partners got para IV notification from Watson Labs Says to defend Lidoderm's intellectual property rights Shares down 3 pct pre-market Jan 19 (Reuters) - Endo Pharmaceuticals Holdings Inc said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback